Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 71610-157

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 150 mg (71610 0157 60)

This is a prescription medication, Divalproex Sodium ER, with a strength of 250mg and 90 tablets per bottle. NOC# 71610.0157:60 is written in the label, and there is an inventory control code (Dmaex Sodium ER 250mg 90 Tablets) at the bottom.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Divalproex Fig1)

The text describes a figure, labeled as "Figure 1", which shows the reduction percentage in CPS rate of patients taking Divalproex Sodium Delayed-Release Tablets compared to those taking placebo. The figure also indicates the percentage of patients who experienced improvement, no change, or worsening of their condition.*

FDA Label Image

Figure 2 (Divalproex Fig2)

FDA Label Image

Figure-3 (Divalproex Fig3)

This appears to be a mix of numerical values and a drug name "Divalproex Sodium Extended-Release Tablets". Without additional context, it is not possible to provide a useful description.*

FDA Label Image

Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.